UniProt ID | INT12_HUMAN | |
---|---|---|
UniProt AC | Q96CB8 | |
Protein Name | Integrator complex subunit 12 | |
Gene Name | INTS12 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 462 | |
Subcellular Localization | Nucleus . | |
Protein Description | Component of the Integrator complex, a complex involved in the small nuclear RNAs (snRNA) U1 and U2 transcription and in their 3'-box-dependent processing. The Integrator complex is associated with the C-terminal domain (CTD) of RNA polymerase II largest subunit (POLR2A) and is recruited to the U1 and U2 snRNAs genes. [PubMed: 16239144 Mediates recruitment of cytoplasmic dynein to the nuclear envelope, probably as component of the INT complex] | |
Protein Sequence | MAATVNLELDPIFLKALGFLHSKSKDSAEKLKALLDESLARGIDSSYRPSQKDVEPPKISSTKNISIKQEPKISSSLPSGNNNGKVLTTEKVKKEAEKRPADKMKSDITEGVDIPKKPRLEKPETQSSPITVQSSKDLPMADLSSFEETSADDFAMEMGLACVVCRQMMVASGNQLVECQECHNLYHRDCHKPQVTDKEANDPRLVWYCARCTRQMKRMAQKTQKPPQKPAPAVVSVTPAVKDPLVKKPETKLKQETTFLAFKRTEVKTSTVISGNSSSASVSSSVTSGLTGWAAFAAKTSSAGPSTAKLSSTTQNNTGKPATSSANQKPVGLTGLATSSKGGIGSKIGSNNSTTPTVPLKPPPPLTLGKTGLSRSVSCDNVSKVGLPSPSSLVPGSSSQLSGNGNSGTSGPSGSTTSKTTSESSSSPSASLKGPTSQESQLNAMKRLQMVKKKAAQKKLKK | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
45 | Phosphorylation | SLARGIDSSYRPSQK HHHCCCCCCCCCCCC | 27.61 | 28787133 | |
46 | Phosphorylation | LARGIDSSYRPSQKD HHCCCCCCCCCCCCC | 22.78 | 28348404 | |
50 | Phosphorylation | IDSSYRPSQKDVEPP CCCCCCCCCCCCCCC | 40.64 | 28348404 | |
60 | Phosphorylation | DVEPPKISSTKNISI CCCCCCCCCCCCCCC | 37.77 | 24719451 | |
61 | Phosphorylation | VEPPKISSTKNISIK CCCCCCCCCCCCCCC | 47.04 | 28348404 | |
63 | Acetylation | PPKISSTKNISIKQE CCCCCCCCCCCCCCC | 54.99 | 25953088 | |
66 | Phosphorylation | ISSTKNISIKQEPKI CCCCCCCCCCCCCCC | 32.88 | 23186163 | |
68 | Acetylation | STKNISIKQEPKISS CCCCCCCCCCCCCCC | 41.64 | 23749302 | |
68 | Sumoylation | STKNISIKQEPKISS CCCCCCCCCCCCCCC | 41.64 | 28112733 | |
68 | Sumoylation | STKNISIKQEPKISS CCCCCCCCCCCCCCC | 41.64 | - | |
79 | Phosphorylation | KISSSLPSGNNNGKV CCCCCCCCCCCCCCE | 60.49 | 26714015 | |
85 | Acetylation | PSGNNNGKVLTTEKV CCCCCCCCEEEHHHH | 35.87 | 23236377 | |
91 | Acetylation | GKVLTTEKVKKEAEK CCEEEHHHHHHHHHH | 58.21 | 25953088 | |
94 | Acetylation | LTTEKVKKEAEKRPA EEHHHHHHHHHHCCH | 66.21 | 7299073 | |
105 | Sumoylation | KRPADKMKSDITEGV HCCHHHHCCCCCCCC | 51.20 | - | |
105 | Sumoylation | KRPADKMKSDITEGV HCCHHHHCCCCCCCC | 51.20 | - | |
106 | Phosphorylation | RPADKMKSDITEGVD CCHHHHCCCCCCCCC | 30.65 | 20068231 | |
109 | Phosphorylation | DKMKSDITEGVDIPK HHHCCCCCCCCCCCC | 31.51 | 20068231 | |
122 | Methylation | PKKPRLEKPETQSSP CCCCCCCCCCCCCCC | 53.39 | - | |
122 | Acetylation | PKKPRLEKPETQSSP CCCCCCCCCCCCCCC | 53.39 | 25953088 | |
125 | Phosphorylation | PRLEKPETQSSPITV CCCCCCCCCCCCEEE | 42.13 | 30266825 | |
127 | Phosphorylation | LEKPETQSSPITVQS CCCCCCCCCCEEECC | 45.56 | 29255136 | |
128 | Phosphorylation | EKPETQSSPITVQSS CCCCCCCCCEEECCC | 15.54 | 29255136 | |
131 | Phosphorylation | ETQSSPITVQSSKDL CCCCCCEEECCCCCC | 18.84 | 30266825 | |
134 | Phosphorylation | SSPITVQSSKDLPMA CCCEEECCCCCCCCC | 34.71 | 23927012 | |
135 | Phosphorylation | SPITVQSSKDLPMAD CCEEECCCCCCCCCC | 17.07 | 23927012 | |
192 | Ubiquitination | LYHRDCHKPQVTDKE CCCCCCCCCCCCCCC | 43.40 | - | |
198 | Ubiquitination | HKPQVTDKEANDPRL CCCCCCCCCCCCHHH | 49.73 | - | |
222 | Acetylation | QMKRMAQKTQKPPQK HHHHHHHHHCCCCCC | 43.30 | 19822337 | |
229 | Acetylation | KTQKPPQKPAPAVVS HHCCCCCCCCCCEEE | 49.25 | 19822345 | |
247 | Ubiquitination | AVKDPLVKKPETKLK HHCCCCCCCCCCCCC | 71.00 | - | |
254 | Sumoylation | KKPETKLKQETTFLA CCCCCCCCCCEEEEE | 47.87 | 28112733 | |
254 | Sumoylation | KKPETKLKQETTFLA CCCCCCCCCCEEEEE | 47.87 | - | |
257 | Phosphorylation | ETKLKQETTFLAFKR CCCCCCCEEEEEEEE | 21.98 | 23403867 | |
258 | Phosphorylation | TKLKQETTFLAFKRT CCCCCCEEEEEEEEC | 18.85 | 23403867 | |
263 | Acetylation | ETTFLAFKRTEVKTS CEEEEEEEECEEEEE | 53.45 | 25953088 | |
279 | Phosphorylation | VISGNSSSASVSSSV EEECCCCCCCCCHHH | 25.12 | 22210691 | |
281 | Phosphorylation | SGNSSSASVSSSVTS ECCCCCCCCCHHHHC | 25.20 | 22210691 | |
287 | Phosphorylation | ASVSSSVTSGLTGWA CCCCHHHHCCCCHHH | 21.01 | 22210691 | |
311 | O-linked_Glycosylation | GPSTAKLSSTTQNNT CCCCEECCCCCCCCC | 25.57 | 30059200 | |
314 | O-linked_Glycosylation | TAKLSSTTQNNTGKP CEECCCCCCCCCCCC | 31.11 | 30059200 | |
318 | O-linked_Glycosylation | SSTTQNNTGKPATSS CCCCCCCCCCCCCCC | 54.88 | 30059200 | |
320 | Ubiquitination | TTQNNTGKPATSSAN CCCCCCCCCCCCCCC | 29.46 | - | |
320 | Acetylation | TTQNNTGKPATSSAN CCCCCCCCCCCCCCC | 29.46 | 26051181 | |
323 | O-linked_Glycosylation | NNTGKPATSSANQKP CCCCCCCCCCCCCCC | 31.57 | 30059200 | |
324 | O-linked_Glycosylation | NTGKPATSSANQKPV CCCCCCCCCCCCCCC | 29.56 | 30059200 | |
325 | O-linked_Glycosylation | TGKPATSSANQKPVG CCCCCCCCCCCCCCC | 27.21 | 30059200 | |
329 | Ubiquitination | ATSSANQKPVGLTGL CCCCCCCCCCCEECE | 41.29 | - | |
329 | Acetylation | ATSSANQKPVGLTGL CCCCCCCCCCCEECE | 41.29 | 26051181 | |
338 | O-linked_Glycosylation | VGLTGLATSSKGGIG CCEECEECCCCCCCC | 38.28 | 30059200 | |
340 | Phosphorylation | LTGLATSSKGGIGSK EECEECCCCCCCCCC | 30.85 | 25627689 | |
341 | Acetylation | TGLATSSKGGIGSKI ECEECCCCCCCCCCC | 62.01 | 26051181 | |
347 | Acetylation | SKGGIGSKIGSNNST CCCCCCCCCCCCCCC | 45.96 | 25953088 | |
350 | Phosphorylation | GIGSKIGSNNSTTPT CCCCCCCCCCCCCCC | 35.99 | 27251275 | |
353 | Phosphorylation | SKIGSNNSTTPTVPL CCCCCCCCCCCCCCC | 37.60 | 27251275 | |
354 | Phosphorylation | KIGSNNSTTPTVPLK CCCCCCCCCCCCCCC | 38.63 | 25159151 | |
355 | Phosphorylation | IGSNNSTTPTVPLKP CCCCCCCCCCCCCCC | 19.45 | 25159151 | |
357 | Phosphorylation | SNNSTTPTVPLKPPP CCCCCCCCCCCCCCC | 32.44 | 27251275 | |
361 | Acetylation | TTPTVPLKPPPPLTL CCCCCCCCCCCCCCC | 49.78 | 25953088 | |
367 | Phosphorylation | LKPPPPLTLGKTGLS CCCCCCCCCCCCCCC | 38.96 | 27251275 | |
370 | Acetylation | PPPLTLGKTGLSRSV CCCCCCCCCCCCCCC | 42.40 | 25953088 | |
371 | Phosphorylation | PPLTLGKTGLSRSVS CCCCCCCCCCCCCCC | 41.37 | 29514088 | |
374 | Phosphorylation | TLGKTGLSRSVSCDN CCCCCCCCCCCCCCC | 24.69 | 29514088 | |
376 | Phosphorylation | GKTGLSRSVSCDNVS CCCCCCCCCCCCCCH | 18.27 | 30266825 | |
378 | Phosphorylation | TGLSRSVSCDNVSKV CCCCCCCCCCCCHHC | 19.59 | 23401153 | |
383 | Phosphorylation | SVSCDNVSKVGLPSP CCCCCCCHHCCCCCH | 28.07 | 29396449 | |
389 | Phosphorylation | VSKVGLPSPSSLVPG CHHCCCCCHHHCCCC | 42.32 | 25159151 | |
391 | Phosphorylation | KVGLPSPSSLVPGSS HCCCCCHHHCCCCCC | 40.41 | 25159151 | |
392 | Phosphorylation | VGLPSPSSLVPGSSS CCCCCHHHCCCCCCC | 36.45 | 25627689 | |
397 | Phosphorylation | PSSLVPGSSSQLSGN HHHCCCCCCCCCCCC | 22.27 | 29978859 | |
398 | Phosphorylation | SSLVPGSSSQLSGNG HHCCCCCCCCCCCCC | 28.19 | 29978859 | |
399 | Phosphorylation | SLVPGSSSQLSGNGN HCCCCCCCCCCCCCC | 36.52 | 29978859 | |
402 | Phosphorylation | PGSSSQLSGNGNSGT CCCCCCCCCCCCCCC | 23.68 | 29978859 | |
407 | Phosphorylation | QLSGNGNSGTSGPSG CCCCCCCCCCCCCCC | 44.86 | 23186163 | |
419 | Methylation | PSGSTTSKTTSESSS CCCCCCCCCCCCCCC | 54.45 | - | |
420 | Phosphorylation | SGSTTSKTTSESSSS CCCCCCCCCCCCCCC | 35.01 | 27251275 | |
421 | Phosphorylation | GSTTSKTTSESSSSP CCCCCCCCCCCCCCC | 33.94 | 27251275 | |
422 | Phosphorylation | STTSKTTSESSSSPS CCCCCCCCCCCCCCC | 40.49 | 25627689 | |
424 | Phosphorylation | TSKTTSESSSSPSAS CCCCCCCCCCCCCCC | 34.97 | 29396449 | |
425 | Phosphorylation | SKTTSESSSSPSASL CCCCCCCCCCCCCCC | 30.68 | 25262027 | |
426 | Phosphorylation | KTTSESSSSPSASLK CCCCCCCCCCCCCCC | 56.39 | 25262027 | |
427 | Phosphorylation | TTSESSSSPSASLKG CCCCCCCCCCCCCCC | 25.48 | 25159151 | |
429 | Phosphorylation | SESSSSPSASLKGPT CCCCCCCCCCCCCCC | 32.22 | 22199227 | |
431 | Phosphorylation | SSSSPSASLKGPTSQ CCCCCCCCCCCCCCH | 34.64 | 22199227 | |
433 | Methylation | SSPSASLKGPTSQES CCCCCCCCCCCCHHH | 61.42 | 115974929 | |
436 | Phosphorylation | SASLKGPTSQESQLN CCCCCCCCCHHHHHH | 52.27 | 27174698 | |
437 | Phosphorylation | ASLKGPTSQESQLNA CCCCCCCCHHHHHHH | 34.77 | 25159151 | |
440 | Phosphorylation | KGPTSQESQLNAMKR CCCCCHHHHHHHHHH | 32.12 | 27174698 | |
446 | Acetylation | ESQLNAMKRLQMVKK HHHHHHHHHHHHHHH | 47.77 | 25953088 | |
446 | Ubiquitination | ESQLNAMKRLQMVKK HHHHHHHHHHHHHHH | 47.77 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of INT12_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of INT12_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of INT12_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
A4_HUMAN | APP | physical | 21832049 | |
INT1_HUMAN | INTS1 | physical | 26344197 | |
INT1_HUMAN | INTS1 | physical | 28514442 | |
GT2D1_HUMAN | GTF2IRD1 | physical | 26275350 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-127; SER-128 ANDSER-427, AND MASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-128, AND MASSSPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-128 AND SER-427, ANDMASS SPECTROMETRY. |